VANCOUVER, BC / ACCESS Newswire / March 24, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery sys ...

The acquisition aligns with The Lockwood Group's ongoing growth strategy, which includes expanding market access and commercialization support services. In recent years, Nexus Health has broadened its ...

VANCOUVER, BC / ACCESSWIRE / November 20, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to provide further details on its clinical and ...

Vancouver, BC & Edinburgh, Scotland, March 05, 2026 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global ” or the “Company ”) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded ...

The pharmaceutical commercialization landscape is becoming increasingly complex. Tried and true paradigms for capturing market share and securing reimbursement must evolve in the face of demand for ...

Biolab Farmacêutica gains exclusive rights in Brazil to GMRx2, an innovative single pill combination of three medicines, including two doses that are lower than those currently available in single ...

Sorond indicated a continued commitment to "advancing PNT resiliency in support of national security, public safety and economic stability," and emphasized focus on executing the strategic road map ...

When the topic of technology commercialization strategies comes up, the most common options typically mentioned include the sale of a technology or building a business around technology by selling ...

VANCOUVER, BC / ACCESS Newswire / March 24, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

Lo, Ph.D., Professor at the MIT Sloan School of Management and a member of n-Lorem’s board of directors, have published a commentary in Nature Biotechnology that proposes more economically feasible ...